Standard Biotools (LAB) EBITDA Margin (2010 - 2026)
Standard Biotools (LAB) reported EBITDA Margin of 59.09% for Q1 2026, up 7428.0% year-over-year from 0.78% in Q1 2025, and up 42.94% on a QoQ basis from 103.57% in Q4 2025.
Standard Biotools (LAB) has 17 years of EBITDA Margin data on file, last reported at 59.09% in Q1 2026.
- Quarterly EBITDA Margin rose 7428.0% year-over-year to 59.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 111.04% (down 10935.0% YoY) and the FY2025 annual result came in at 129.2%, down 10834.0% from the prior year.
- EBITDA Margin grew to 59.09% in Q1 2026 per LAB's latest filing, from 103.57% in the prior quarter.
- Across five years, EBITDA Margin topped out at 332.65% in Q4 2024 and bottomed at 205.37% in Q2 2022.
- The 5-year median for EBITDA Margin is 103.77% (2022), against an average of 71.17%.
- The widest annual swing landed in 2023, when EBITDA Margin jumped 21873 bps; it then plunged 43622 bps in 2025.
- Tracing LAB's EBITDA Margin over 5 years: stood at 78.13% in 2022, then jumped by 280 bps to 140.6% in 2023, then jumped by 137 bps to 332.65% in 2024, then slumped by 131 bps to 103.57% in 2025, then soared by 43 bps to 59.09% in 2026.
- Per Business Quant, the three latest LAB EBITDA Margin figures stand at 59.09% (Q1 2026), 103.57% (Q4 2025), and 168.46% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | -59.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.09% |
| Dec 31, 2025 | -103.57% |
| Sep 30, 2025 | -168.46% |
| Jun 30, 2025 | -118.08% |
| Mar 31, 2025 | -133.37% |
| Dec 31, 2024 | 332.65% |
| Sep 30, 2024 | -120.89% |
| Jun 30, 2024 | -134.54% |
| Mar 31, 2024 | -132.15% |
| Dec 31, 2023 | 140.60% |
| Sep 30, 2023 | -83.46% |
| Jun 30, 2023 | -63.07% |
| Mar 31, 2023 | -66.06% |
| Dec 31, 2022 | -78.13% |
| Sep 30, 2022 | -113.18% |
| Jun 30, 2022 | -205.37% |
| Mar 31, 2022 | -103.77% |
| Sep 30, 2021 | -68.80% |
| Jun 30, 2021 | -55.67% |
| Mar 31, 2021 | -58.91% |
| Dec 31, 2020 | -37.89% |
| Sep 30, 2020 | -13.71% |
| Jun 30, 2020 | -52.67% |
| Mar 31, 2020 | -482.00% |
| Dec 31, 2019 | -28.30% |
| Sep 30, 2019 | -52.14% |
| Jun 30, 2019 | -51.91% |
| Mar 31, 2019 | -47.18% |
| Dec 31, 2018 | -34.39% |
| Sep 30, 2018 | -40.15% |
| Jun 30, 2018 | -48.38% |
| Mar 31, 2018 | -50.04% |
| Dec 31, 2017 | -31.48% |
| Sep 30, 2017 | -63.05% |
| Jun 30, 2017 | -68.95% |
| Mar 31, 2017 | -68.68% |
| Dec 31, 2016 | -70.55% |
| Sep 30, 2016 | -83.29% |
| Jun 30, 2016 | -64.41% |
| Mar 31, 2016 | -65.06% |
| Dec 31, 2015 | -44.57% |
| Sep 30, 2015 | -27.24% |
| Jun 30, 2015 | -51.22% |
| Mar 31, 2015 | -52.38% |
| Dec 31, 2014 | -29.36% |
| Sep 30, 2014 | -44.03% |
| Jun 30, 2014 | -44.83% |
| Mar 31, 2014 | -60.03% |
| Dec 31, 2013 | -22.24% |
| Sep 30, 2013 | -22.99% |
| Jun 30, 2013 | -22.83% |
| Mar 31, 2013 | -24.46% |
| Dec 31, 2012 | -22.31% |
| Sep 30, 2012 | -32.42% |
| Jun 30, 2012 | -35.40% |
| Mar 31, 2012 | -61.33% |
| Dec 31, 2011 | -22.92% |
| Sep 30, 2011 | -42.06% |
| Jun 30, 2011 | -67.80% |
| Mar 31, 2011 | -84.51% |
| Dec 31, 2010 | -20.98% |
| Sep 30, 2010 | -744.95% |
| Jun 30, 2010 | -52.67% |